Immatics NV (IMTX)
7.58
-0.22
(-2.82%)
USD |
NASDAQ |
Nov 21, 16:00
7.586
+0.01
(+0.08%)
After-Hours: 20:00
Immatics Profit Margin (Quarterly): -16.95% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -16.95% |
| June 30, 2024 | -96.09% |
| March 31, 2024 | -10.09% |
| December 31, 2023 | -164.2% |
| September 30, 2023 | -447.0% |
| June 30, 2023 | -110.1% |
| March 31, 2023 | -201.6% |
| December 31, 2022 | -35.15% |
| September 30, 2022 | -139.0% |
| June 30, 2022 | -81.21% |
| March 31, 2022 | 83.24% |
| Date | Value |
|---|---|
| December 31, 2021 | -106.7% |
| September 30, 2021 | -422.2% |
| June 30, 2021 | -511.4% |
| March 31, 2021 | -308.2% |
| December 31, 2020 | -190.2% |
| September 30, 2020 | -2.08K% |
| June 30, 2020 | -305.1% |
| March 31, 2020 | -118.0% |
| December 31, 2019 | -335.6% |
| September 30, 2019 | -93.18% |
| June 30, 2019 | -120.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.08K%
Minimum
Sep 2020
83.24%
Maximum
Mar 2022
-279.9%
Average
-151.6%
Median
Profit Margin (Quarterly) Benchmarks
| Affimed NV | -9.77K% |
| InflaRx NV | -14.09K% |
| BioNTech SE | 15.91% |
| CureVac NV | 68.44% |
| ATAI Life Sciences NV | -65.72K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -16.87% |
| Return on Assets | -9.89% |
| Return on Invested Capital | -16.87% |
| Operating Margin (Quarterly) | 1.02% |
| Return on Net Operating Assets | -72.40% |